Strategy
MSTR
Coinbase
COIN
Alphabet-A
GOOGL
Alphabet-C
GOOG
NVIDIA
NVDA
US Stock MarketDetailed Quotes
PGNY Progyny
- 21.560
- -0.440-2.00%
Close Mar 4 16:00 ET
1.84BMarket Cap37.82P/E (TTM)
21.840High20.904Low2.51MVolume21.670Open22.000Pre Close53.80MTurnover3.48%Turnover Ratio37.82P/E (Static)85.41MShares38.98052wk High4.36P/B1.55BFloat Cap13.39052wk Low--Dividend TTM71.99MShs Float68.320Historical High--Div YieldTTM4.26%Amplitude13.290Historical Low21.461Avg Price1Lot Size
About Progyny Company
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Company Profile
SymbolPGNY
Company NameProgyny
Listing DateOct 25, 2019
Issue Price13.00
Founded2008
CEOMr. Peter Anevski
MarketNASDAQ
Employees566
Fiscal Year Ends12-31
Address1359 Broadway
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10018
Phone1-212-888-3124
Websitehttp://www.progyny.com
Company Executives
- Name
- Position
- Salary
- Peter Anevski
- Director and Chief Executive Officer
- 1.09M
- Mark Livingston
- Chief Financial Officer and Principal Accounting Officer
- 1.40M
- Allison Swartz
- Executive Vice President, General Counsel and Secretary
- 546.22K
- David J. Schlanger
- Executive Chairman of the Board
- 513.57K
- Michael Sturmer
- President
- 1.49M
- Debra L. Morris
- Director
- --
- Roger C. Holstein
- Independent Director
- 518.30K
- Lloyd H. Dean
- Independent Director
- 518.30K
- Kevin K. Gordon
- Independent Director
- 518.30K
- Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
- Independent Director
- 583.35K
- Cheryl Scott
- Independent Director
- 518.30K
- Jeffrey Park
- Lead Independent Director
- 606.88K
- Dr. Beth C. Seidenberg,M.D.
- Lead Independent Director
- 653.39K
- Dr. Norman C. Payson,M.D.
- Independent Director
- 567.30K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.